Online first
Original Article
Published online: 2025-02-12
Factors influencing Systemic Coronary Risk Estimation 2 (SCORE2)
1
, 123, 4, 2, 2, 12
, 123, 4, 2, 2, 12
DOI: 10.5603/cj.95922
Pubmed: 39936848
Abstract
Background: This study aimed to identify factors associated with the 10-year risk of fatal and non-fatal cardiovascular disease (CVD) events in apparently healthy individuals aged 40–69 years.
Methods: 148 patients without established CVD were divided into low-risk (70 patients) and high-risk (78 patients) groups based on their CVD risk in SCORE2.
Results: High-risk patients presented with higher left atrial volume index (LAVI) (p = 0.003), left ventricular mass index (LVMI) (p < 0.001), and ratio of peak velocity of early diastolic transmitral flow to peak velocity of early diastolic mitral annular motion (E/E’) (p < 0.001) but lower oxygen uptake at anaerobic threshold (VO2AT) (p = 0.02) and maximal oxygen uptake (VO2max) (p = 0.008), compared to their counterparts. High-risk patients also had higher values of high-sensitivity cardiac troponin T (hs-cTnT) (p < 0.001) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (p<0.001), and lower level of glomerular filtration rate (GFR) (p < 0.001). In a multiple logistic regression model, E/E’ > 6.75 cm/s (OR 3.9, 95% CI: 1.5-10.3; p = 0.004) and hs-cTnT > 4.8 pg/ml (OR 6.02, 95% CI: 2.3-15.8; p < 0.001) were independently associated with high and very high CVD risk. SCORE2 (%) correlated positively with metabolic age (R Spearman = 0.79; p < 0.001), hs-cTnT (R = 0.6; p < 0.001), and NT-proBNP (R = 0.5; p < 0.001) and negatively with GFR (R = –0.5; p < 0.001) and VO2max (ml/min/kg) (R = –0.3; p < 0.001).
Conclusions: Elevated E/E’ and higher hs-cTnT level independently predict high and very high risk in SCORE2. The increasing 10-year cardiovascular disease risk correlates with higher metabolic age, higher levels of NT-proBNP and hs-cTnT, and lower level of GFR.
Keywords: SCORE2CVD riskcoronary artery diseaseatherosclerosisspiroergometry
References
- Visseren FLJ, Mach F, Smulders YM, et al. ESC Scientific Document Group, ESC Scientific Document Group, ESC Scientific Document Group, ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227–3337.
- Roth GA, Mensah GA, Johnson CO, et al. GBD 2019 Stroke Collaborators, GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25): 2982–3021.
- SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021; 42(25): 2439–2454.
- Conroy RM, Pyörälä K, Fitzgerald AP, et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11): 987–1003.
- Ferraro RA, Leucker T, Martin SS, et al. Contemporary Management of Dyslipidemia. Drugs. 2022; 82(5): 559–576.
- Correction to: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 139(25): e1182–e1186.
- Viera AJ, Reamy BV. Jr. Cardiovascular Disease Prevention: Risk Assessment. FP Essent. 2022; 520: 8–14.
- Barrios V, Escobar C, Banach M. Primary prevention. The cornerstone to reduce the burden of cardiovascular disease. Rev Esp Cardiol (Engl Ed). 2021; 74(10): 827–828.
- Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019; 32(1): 1–64.
- Kosaraju A, Goyal A, Grigorova Y, et al. Left Ventricular Ejection Fraction. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
- Zhang X, Wei X, Kong L, et al. Evaluating the left ventricular global systolic function of patients with diabetes mellitus by the real-time three-plane speckle tracking imaging]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013; 30(3): 513–517.
- Tousignant C, Kim H, Papa F, et al. Evaluation of TAPSE as a measure of right ventricular output. Can J Anaesth. 2012; 59(4): 376–383.
- Datta D, Normandin E, ZuWallack R. Cardiopulmonary exercise testing in the assessment of exertional dyspnea. Ann Thorac Med. 2015; 10(2): 77–86.
- Pierce R. Spirometry: an essential clinical measurement. Aust Fam Physician. 2005; 34(7): 535–539.
- Bjørke AC, Raastad T, Berntsen S. Criteria for the determination of maximal oxygen uptake in patients newly diagnosed with cancer: Baseline data from the randomized controlled trial of physical training and cancer (Phys-Can). PLoS One. 2020; 15(6): e0234507.
- Grinstein J, Sawalha Y, Medvedofsky DA, et al. VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: a fresh look at cardiopulmonary stress testing for prognostication. J Artif Organs. 2021; 24(4): 425–432.
- Marra M, Sammarco R, De Lorenzo A, et al. Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview. Contrast Media Mol Imaging. 2019; 2019: 3548284.
- Park I, Lee JH, Jang DH, et al. Assessment of body water distribution in patients with sepsis during fluid resuscitation using multi-frequency direct segmental bioelectrical impedance analysis. Clin Nutr. 2020; 39(6): 1826–1831.
- Bi X, Forde CG, Goh AiT, et al. Basal Metabolic Rate and Body Composition Predict Habitual Food and Macronutrient Intakes: Gender Differences. Nutrients. 2019; 11(11).
- Sørensen TIA, Martinez AR, Jørgensen TS. Epidemiology of Obesity. Handb Exp Pharmacol. 2022; 274: 3–27.
- Nuttall FQ. Body Mass Index: Obesity, BMI, and Health: A Critical Review. Nutr Today. 2015; 50(3): 117–128.
- Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999; 341(15): 1097–1105.
- Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995; 333(11): 677–685.
- Folsom AR, Stevens J, Schreiner PJ, et al. Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Atherosclerosis Risk in Communities Study Investigators. Am J Epidemiol. 1998; 148(12): 1187–1194.
- Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5): 968–977.
- Ndumele CE, Matsushita K, Lazo M, et al. Obesity and Subtypes of Incident Cardiovascular Disease. J Am Heart Assoc. 2016; 5(8).
- Wilson PWF, Bozeman SR, Burton TM, et al. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation. 2008; 118(2): 124–130.
- Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med. 2014; 174(1): 15–22.
- Lu Y, Hajifathalian K, Ezzati M, et al. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects). Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014; 383(9921): 970–983.
- Tan BYQ, Ho JS, Sia CH, et al. Left Atrial Volume Index Predicts New-Onset Atrial Fibrillation and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source. Cerebrovasc Dis. 2020; 49(3): 285–291.
- Gunasekaran R, Maskon O, Hassan HH, et al. Left atrial volume index is an independent predictor of major adverse cardiovascular events in acute coronary syndrome. Can J Cardiol. 2012; 28(5): 561–566.
- Ri T, Saito C, Arashi H, et al. Increased left atrial volume index is associated with more cardiovascular events in patients with acute coronary syndrome: HIJ-PROPER study findings. Echocardiography. 2022; 39(2): 260–267.
- Bombelli M, Facchetti R, Carugo S, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens. 2009; 27(12): 2458–2464.
- Nagueh S, Mikati I, Kopelen H, et al. Doppler Estimation of Left Ventricular Filling Pressure in Sinus Tachycardia. Circulation. 1998; 98(16): 1644–1650.
- Hillis GS, Møller JE, Pellikka PA. Noninvasive estimation of left ventricular filling pressure by e/é is a powerful predictor of survival after acute myocardial infarction. ACC Current Journal Review. 2004; 13(5): 42.
- Wang M, Yip GWK, Wang AYM, et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol. 2003; 41(5): 820–826.
- Hawkins MN, Raven PB, Snell PG, et al. Maximal oxygen uptake as a parametric measure of cardiorespiratory capacity. Med Sci Sports Exerc. 2007; 39(1): 103–107.
- Bielecka-Dabrowa A, Gryglewska K, Sakowicz A, et al. Obesity and Body Mass Components Influence Exercise Tolerance and the Course of Hypertension in Perimenopausal Women. J Cardiovasc Dev Dis. 2022; 9(8).
- Bielecka-Dabrowa A, Gryglewska K, Sakowicz A, et al. Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension. J Pers Med. 2021; 11(8).
- Caron J, duManoir GR, Labrecque L, et al. Impact of type 2 diabetes on cardiorespiratory function and exercise performance. Physiol Rep. 2017; 5(4).
- Allen BR, Christenson RH, Cohen SA, et al. Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort. Circulation. 2021; 143(17): 1659–1672.
- Sandoval Y, Bielinski SJ, Daniels LB, et al. Atherosclerotic Cardiovascular Disease Risk Stratification Based on Measurements of Troponin and Coronary Artery Calcium. J Am Coll Cardiol. 2020; 76(4): 357–370.
- Stelzle D, Shah ASV, Anand A, et al. High-STEACS investigators. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015; 386(10012): 2481–2488.
- Parikh RH, Seliger SL, de Lemos J, et al. Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis. Clin Chem. 2015; 61(12): 1524–1531.
- Willeit P, Welsh P, Evans JDW, et al. High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants. J Am Coll Cardiol. 2017; 70(5): 558–568.
- Niccoli G, Conte M, Marchitti S, et al. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Cardiovasc Revasc Med. 2016; 17(3): 162–168.
- Wu N, Ma F, Guo Y, et al. Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction. Chin Med J (Engl). 2014; 127(4): 627–632.
- Daniels LB, Clopton P, deFilippi CR, et al. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2015; 170(6): 1170–1183.
- Silverman MG, Ference BA, Im K, et al. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA. 2016; 316(12): 1289–1297.
- Sarnak MJ, Levey AS, Schoolwerth AC, et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108(17): 2154–2169.
- Subbiah AK, Chhabra YK, Mahajan S. Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia. 2016; 8(2): 56–61.
